A Phase 1, First in Human Study of TORL-4-500 in Patients with Advanced Cancer
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedcompletion around
- Principal Investigator
- by Lee S. Rosen, MD (ucla)

Description
Summary
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Lee S. Rosen, MD (ucla)
HS Clinical Professor, Medicine. Authored (or co-authored) 116 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- TORL Biotherapeutics, LLC
- ID
- NCT06005740
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 70 study participants
- Last Updated